Subramanian Shankar
Overview
Explore the profile of Subramanian Shankar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
1802
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shankar S
Med J Armed Forces India
. 2022 Sep;
78(Suppl 1):S1-S6.
PMID: 36147437
No abstract available.
2.
Shankar S, Mohakuda S, Kumar A, Nazneen P, Yadav A, Chatterjee K, et al.
Med J Armed Forces India
. 2021 Aug;
77:S385-S392.
PMID: 34334908
Background: Various mathematical models were published to predict the epidemiological consequences of the COVID-19 pandemic. This systematic review has studied the initial epidemiological models. Methods: Articles published from January to...
3.
Muthukrishnan J, Vardhan V, Mangalesh S, Koley M, Shankar S, Yadav A, et al.
Med J Armed Forces India
. 2021 Aug;
77:S278-S282.
PMID: 34334894
Background: Efficacy of vaccines studied in clinical trial settings are likely to be different from their effectiveness in a real-world scenario. Indian Armed Forces launched its vaccine drive against COVID-19...
4.
Ghosh S, Shankar S, Chatterjee K, Chatterjee K, Yadav A, Pandya K, et al.
Med J Armed Forces India
. 2021 Aug;
77:S264-S270.
PMID: 34334892
Background: On 16 Jan 2021, India launched its immunization program against COVID-19. Among the first recipients were 1.59 million Health Care Workers (HCWs) and Frontline Workers (FLWs) of the Indian...
5.
Singh A, Sachan A, Shankar S
Aliment Pharmacol Ther
. 2021 May;
53(11):1244-1245.
PMID: 33961710
No abstract available.
6.
Chatterjee K, Shankar S, Chatterjee K, Yadav A
Med J Armed Forces India
. 2020 Aug;
76(4):387-394.
PMID: 32836711
Background: With the rise of Coronavirus disease 2019 (COVID-19) cases in India, lockdown was imposed from March 25, 2020. We studied post-lockdown scenarios and evaluated health-care constraints. Our aim was...
7.
Chatterjee K, Chatterjee K, Kumar A, Shankar S
Med J Armed Forces India
. 2020 Apr;
76(2):147-155.
PMID: 32292232
Background: In India, the SARS-CoV-2 COVID-19 epidemic has grown to 1251 cases and 32 deaths as on 30 Mar 2020. The healthcare impact of the epidemic in India was studied...
8.
Nair V, Vasdev V, Kumar A, Shankar S, Nair V, Sharma A
Int J Rheum Dis
. 2018 Feb;
21(4):859-865.
PMID: 29392863
Aim: To prospectively evaluate long term outcomes in a cohort of patients with Systemic sclerosis treated with Hematopoietic stem cell transplant (HSCT). Method: This is a prospective observational study of...
9.
Karade S, Chaturbhuj D, Sen S, Joshi R, Kulkarni S, Shankar S, et al.
Int J Infect Dis
. 2017 Nov;
66:33-41.
PMID: 29128646
Objective: The objective of this review was to assess the burden of HIV drug resistance mutations (DRM) in Indian adults exposed to first-line antiretroviral therapy (ART) as per national guidelines....
10.
Ghate M, Kadam D, Gaikwad N, Shankar S, Gurav S, Rahane G, et al.
WHO South East Asia J Public Health
. 2017 Jun;
4(2):123-129.
PMID: 28607310
Background: India has rapidly scaled up its programme for antiretroviral therapy (ART). There is high potential for the emergence of HIV drug resistance (HIVDR), with an increasing number of patients...